AP2002002627A0 - Orally administred controlled delivery system for once daily administration of ciprofloxacin - Google Patents

Orally administred controlled delivery system for once daily administration of ciprofloxacin

Info

Publication number: AP2002002627A0
Authority: AP; ARIPO
Prior art keywords: administred; ciprofloxacin; orally; delivery system; once daily
Prior art date: 2000-03-03

Application number

AP2002002627A

Other versions

AP1485A (en

Original Assignee

Rabaxy Lab Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2001-02-28

Publication date

2002-09-30

2001-02-28 Application filed by Rabaxy Lab Ltd filed Critical Rabaxy Lab Ltd

2002-09-30 Publication of AP2002002627A0 publication Critical patent/AP2002002627A0/en

2005-10-31 Application granted granted Critical

2005-10-31 Publication of AP1485A publication Critical patent/AP1485A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

APAP/P/2002/002627A 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin. AP1485A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51788700A	2000-03-03	2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (2)

Publication Number	Publication Date
AP2002002627A0 true AP2002002627A0 (en)	2002-09-30
AP1485A AP1485A (en)	2005-10-31

Family

ID=24061635

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
APAP/P/2002/002627A AP1485A (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily administration of ciprofloxacin.
APAP/P/2001/002084A AP2001002084A0 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily adminstration of ciprofloxacin

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2001/002084A AP2001002084A0 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily adminstration of ciprofloxacin

Country Status (31)

Country	Link
EP (1)	EP1263409A1 (en)
JP (1)	JP2003525229A (en)
KR (1)	KR20030009374A (en)
CN (1)	CN1420763A (en)
AP (2)	AP1485A (en)
AR (1)	AR032614A1 (en)
AU (1)	AU3589701A (en)
BG (1)	BG107055A (en)
BR (1)	BR0108958A (en)
CA (1)	CA2400950A1 (en)
CZ (1)	CZ20022883A3 (en)
DO (1)	DOP2001000130A (en)
EA (1)	EA200200914A1 (en)
EC (1)	ECSP013952A (en)
EE (1)	EE200200497A (en)
GT (1)	GT200100033A (en)
HN (1)	HN2001000038A (en)
HR (1)	HRP20020715A2 (en)
HU (1)	HUP0204417A3 (en)
IL (1)	IL151553A0 (en)
IS (1)	IS6532A (en)
MX (1)	MXPA02008568A (en)
NO (1)	NO20024108L (en)
NZ (1)	NZ520927A (en)
OA (1)	OA12381A (en)
PE (1)	PE20011113A1 (en)
PL (1)	PL365071A1 (en)
SK (1)	SK12542002A3 (en)
WO (1)	WO2001064183A1 (en)
YU (1)	YU66202A (en)
ZA (1)	ZA200206764B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
US20030229101A1 (en) *	2002-06-06	2003-12-11	Sherman Bernard Charles	Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (en)	2003-11-04	2005-06-09	Bayer Healthcare Ag	Flavor-containing drug formulations with improved pharmaceutical properties
EP1745775B1 (en) *	2005-07-19	2008-05-28	Ethypharm	Gastroretentive formulations and manufacturing process thereof.
EP1880722B1 (en) *	2006-07-19	2010-03-17	Tabuk Pharmaceutical Manufacturing Co.	Pharmaceutical compositions of ciprofloxacin
US10363288B2 (en)	2015-01-14	2019-07-30	National Jewish Health	Insulin mimotopes and methods of using the same
US20190070299A1 (en) *	2016-02-23	2019-03-07	Matripharm International Inc.	Dual-rate release formulation with high drug loading
EP3432877B1 (en)	2016-03-24	2023-01-11	ImmunoMolecular Therapeutics, Inc.	D-alpha-methyldopa for treating autoimmune disease
US11052060B2 (en)	2018-02-12	2021-07-06	The Regents Of The University Of Colorado, A Body Corporate	Compounds and methods for treating autoimmunity
US11013707B2 (en)	2018-03-23	2021-05-25	The Regents Of The University Of Colorado, A Body Corporate	Administration of oral methyldopa
CN109806237A (en) *	2019-03-13	2019-05-28	悦康药业集团上海制药有限公司	A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5096714A (en) *	1988-06-28	1992-03-17	Hauser-Kuhrts, Inc.	Prolonged release drug tablet formulations
JPH0624959A (en) *	1991-10-04	1994-02-01	Bayer Yakuhin Kk	Medice release solid pharmaceutical preparation of gastric suspending type sustained
DE4406424A1 (en) *	1994-02-28	1995-08-31	Bayer Ag	Expandable dosage forms
DE19839057A1 (en) *	1998-08-28	2000-03-02	Koch Berthold	Purge air controller for a drying device for compressed air
ATE245414T1 (en) *	1998-09-14	2003-08-15	Ranbaxy Lab Ltd	ORAL ADMINISTERED SYSTEM FOR TEMPORAL AND SPATIAL CONTROLLED MEDICINAL DELIVERY

2001
- 2001-02-28 YU YU66202A patent/YU66202A/en unknown
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 CN CN01805998A patent/CN1420763A/en active Pending
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Application Discontinuation
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/en unknown
- 2001-02-28 HR HRP20020715 patent/HRP20020715A2/en not_active Application Discontinuation
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/en not_active Ceased
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/en unknown
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 IL IL15155301A patent/IL151553A0/en unknown
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/en unknown
- 2001-02-28 AR ARP010100957A patent/AR032614A1/en not_active Application Discontinuation
- 2001-02-28 NZ NZ520927A patent/NZ520927A/en unknown
- 2001-02-28 PL PL01365071A patent/PL365071A1/en not_active Application Discontinuation
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/en not_active Withdrawn
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 EE EEP200200497A patent/EE200200497A/en unknown
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/en unknown
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/en not_active Withdrawn
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/en unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/en not_active Application Discontinuation
- 2001-03-01 GT GT200100033A patent/GT200100033A/en unknown
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/en unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/en unknown
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/en unknown
- 2002-09-02 BG BG107055A patent/BG107055A/en unknown

Also Published As

Publication number	Publication date
NO20024108L (en)	2002-10-25
YU66202A (en)	2005-09-19
CN1420763A (en)	2003-05-28
CA2400950A1 (en)	2001-09-07
WO2001064183A1 (en)	2001-09-07
AU3589701A (en)	2001-09-12
AR032614A1 (en)	2003-11-19
NZ520927A (en)	2003-06-30
EA200200914A1 (en)	2003-02-27
DOP2001000130A (en)	2004-03-31
GT200100033A (en)	2001-10-25
HUP0204417A2 (en)	2003-05-28
HRP20020715A2 (en)	2004-12-31
OA12381A (en)	2004-09-06
IL151553A0 (en)	2003-04-10
HUP0204417A3 (en)	2005-03-29
BR0108958A (en)	2003-09-30
EE200200497A (en)	2004-02-16
PL365071A1 (en)	2004-12-27
CZ20022883A3 (en)	2003-04-16
MXPA02008568A (en)	2003-02-24
HN2001000038A (en)	2005-03-23
ZA200206764B (en)	2003-03-04
NO20024108D0 (en)	2002-08-28
PE20011113A1 (en)	2001-10-14
SK12542002A3 (en)	2003-05-02
AP1485A (en)	2005-10-31
IS6532A (en)	2002-08-28
ECSP013952A (en)	2002-04-23
JP2003525229A (en)	2003-08-26
KR20030009374A (en)	2003-01-29
AP2001002084A0 (en)	2001-03-31
EP1263409A1 (en)	2002-12-11
BG107055A (en)	2003-06-30

Publication	Publication Date	Title
EP1091732A4 (en)	2006-01-18	Effervescent drug delivery system for oral administration
AU2002235155A1 (en)	2002-06-18	Crystallization inhibition of drugs in transdermal drug delivery systems
AU4334700A (en)	2000-10-23	Pharmaceutical dosage form for pulsatile delivery of methylphenidate
NZ518739A (en)	2004-12-24	Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
HUP0302319A3 (en)	2013-04-29	Pharmaceutical composition for oral administration of active ingredient
AU4059900A (en)	2000-10-23	Improved conjunctival inserts for topical delivery of medication or lubrication
EP1246608A4 (en)	2005-05-18	Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
EP1455697A4 (en)	2009-08-05	Vaginal delivery of drugs
AU2002216701A1 (en)	2002-05-27	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
IL155272A0 (en)	2003-11-23	Systems for optimized drug delivery
NZ513700A (en)	2001-09-28	Oral drug delivery system
PL352547A1 (en)	2003-08-25	Drugs containing inhibitors of human kinase h-sgk
AP2002002627A0 (en)	2002-09-30	Orally administred controlled delivery system for once daily administration of ciprofloxacin
IL145559A0 (en)	2002-06-30	Tolperison-containing pharmaceutical preparation for oral administration
AU2001238346A1 (en)	2001-08-27	Modification of biopolymers for improved drug delivery
AU6528400A (en)	2001-03-19	Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
AU2001270963A1 (en)	2002-02-13	Transdermal drug delivery system
AU2001230898A1 (en)	2001-07-24	Formulations and methods for administration of pharmacologically or biologicallyactive compounds
HUP0204448A3 (en)	2004-07-28	Trnasdermal therapeutic system for the delivery of lerisetron
HK1051811A (en)	2003-08-22	Orally administered controlled delivery system for once daily administration of ciprofloxacin
AU2002222138A1 (en)	2002-06-18	Drug delivery system
GB9902227D0 (en)	1999-03-24	Pharmaceutical composition for topical administration
IL152646A0 (en)	2003-06-24	Dosage of transdermal delivery systems
IL159789A0 (en)	2004-06-20	Active ingredient combination for pharmacological therapy of nicotine dependence
AU2002210580A1 (en)	2002-04-29	Drug delivery system